Your browser doesn't support javascript.
loading
Differential effects of lenalidomide during plasma cell differentiation.
Jourdan, Michel; Cren, Maïlys; Schafer, Peter; Robert, Nicolas; Duperray, Christophe; Vincent, Laure; Ceballos, Patrice; Cartron, Guillaume; Rossi, Jean-François; Moreaux, Jérôme; Chopra, Rajesh; Klein, Bernard.
Afiliação
  • Jourdan M; INSERM, U1040, Montpellier, France.
  • Cren M; CNRS UPR1142, Institute of Human Genetics, Montpellier, France.
  • Schafer P; INSERM, U1040, Montpellier, France.
  • Robert N; Translational Development Department, Celgene Corporation, Summit, NJ, USA.
  • Duperray C; CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France.
  • Vincent L; Cytometry IRB, Montpellier Rio Imaging, Montpellier, France.
  • Ceballos P; CHU Montpellier, Department of Clinical Hematology, Montpellier, France.
  • Cartron G; CHU Montpellier, Department of Clinical Hematology, Montpellier, France.
  • Rossi JF; CHU Montpellier, Department of Clinical Hematology, Montpellier, France.
  • Moreaux J; University Montpellier 1, UFR Medicine, Montpellier, France.
  • Chopra R; CHU Montpellier, Department of Clinical Hematology, Montpellier, France.
  • Klein B; University Montpellier 1, UFR Medicine, Montpellier, France.
Oncotarget ; 7(19): 28096-111, 2016 May 10.
Article em En | MEDLINE | ID: mdl-27057635
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Talidomida / Diferenciação Celular / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Talidomida / Diferenciação Celular / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França